The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
A germline mutation in the androgen receptor gene in two brothers with breast cancer and Reifenstein syndrome
Abstract
Breast cancer in men is rare--among the risk factors that have been identified are a family history of breast cancer and evidence of androgen insufficiency. We report a family in which two brothers who both developed breast cancer had clinical and endocrinological evidence of androgen resistance. Sequence analysis revealed a mutation in the androgen receptor gene on the X chromosome, within the region encoding the DNA binding domain. This is the first report of a germline mutation in a member of the steroid/thyroid hormone receptor superfamily associated with the development of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is also genetic evidence in agreement with a protective role of androgens against breast cancer (186, 187).”
From Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosterone (2003) · cites this paper as [186]
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,394
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy
Spada, A. L., Wilson, E. M., Lubahn, D. B., Harding, A., & Fischbeck, K. (1991) · Nature · doi:10.1038/352077a0 · Cited by 2,801
Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21
Hall, J., Lee, M. K., Newman, B. M., Morrow, J. E., Anderson, L. A., Huey, B., & King, M. (1990) · Science · doi:10.1126/science.2270482 · Cited by 2,544
Pelletier, J., Bruening, W., Kashtan, C. E., Mauer, S. M., Manivel, J. C., Striegel, J. E., Houghton, D. C., Junien, C., Habib, R., & Fouser, L. S. (1991) · Cell · doi:10.1016/0092-8674(91)90194-4 · Cited by 948
MEXILETINE FOR TREATMENT OF CHRONIC PAINFUL DIABETIC NEUROPATHY
Dejgård, A., Petersen, P., & Kastrup, J. (1988) · The Lancet · doi:10.1016/s0140-6736(88)90999-3 · Cited by 532
Mader, S., Kumar, V., de Verneuil, H., & Chambon, P. (1989) · Nature · doi:10.1038/338271a0 · Cited by 500
WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour
Pelletier, J., Bruening, W., Li, F. P., Haber, D. A., Glaser, T. M., & Housman, D. E. (1991) · Nature · doi:10.1038/353431a0 · Cited by 473
Abnormal sexual differentiation and neoplasia
Verp, M. S., & Simpson, J. L. (1987) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(87)90180-4 · Cited by 415
Green, S., Kumar, V., Theulaz, I., Wahli, W., & Chambon, P. (1988) · The EMBO Journal · doi:10.1002/j.1460-2075.1988.tb03168.x · Cited by 270
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 248
The Androgen Receptor: Structure, Mutations, and Antiandrogens
Hirawat, S., Budman, D. R., & Kreis, W. (2003) · Cancer Investigation · doi:10.1081/cnv-120018232 · Cited by 34
Knutsen, T., Mickley, L. A., Ried, T., Green, E. D., du Manoir, S., Schröck, E., Macville, M. V. E., Ning, Y., Robey, R. W., Polymeropoulos, M. H., et al. (1998) · Genes Chromosomes and Cancer · doi:10.1002/(sici)1098-2264(199809)23:1 · Cited by 75
Genetic Heterogeneity in Breast Cancer Susceptibility
Andersen, T. I. (1996) · Acta Oncologica · doi:10.3109/02841869609109913 · Cited by 33
The Steroid/Nuclear Receptors: From Three-Dimensional Structure to Complex Function
Luisi, B. F., Schwabe, J. W. R., & Freedman, L. P. (1994) · Vitamins and hormones · doi:10.1016/s0083-6729(08)61145-0 · Cited by 33
The Differences between Male and Female Breast Cancer
Omene, C. O., & Tiersten, A. (2010) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-12-374271-1.00042-3 · Cited by 32
Androgen receptor coactivator p44/Mep50 in breast cancer growth and invasion
Peng, Y., Li, Y., Gellert, L. L., Zou, X., Wang, J., Singh, B., Xu, R., Chiriboga, L. A., Daniels, G., Pan, R., et al. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00936.x · Cited by 32
Increased frequency of long androgen receptor CAG repeats in male breast cancers
MacLean, H. E., Brown, R. W., Beilin, J., Warne, G. L., & Zajac, J. D. (2004) · Breast Cancer Research and Treatment · doi:10.1007/s10549-004-0781-6 · Cited by 31
Genes responsible for familial breast cancer.
Cornelisse, C., Cornelis, R., & Devilee, P. (1996) · Pathology, Research and Practice · doi:10.1016/s0344-0338(96)80090-2 · Cited by 25
Lumbroso, S., Lobaccaro, J. A., Belon, C., Martin, D., Chaussain, J., & Sultan, C. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)56281-5 · Cited by 31
Little, M. P., & McElvenny, D. M. (2016) · Environmental Health Perspectives · doi:10.1289/ehp151 · Cited by 30
Bergþorsson, J. Þ., Eiríksdóttir, G., Barkardottir, R. B., Egilsson, V., Arason, A., & Ingvarsson, S. (1995) · Human Genetics · doi:10.1007/bf00191803 · Cited by 29
Huusko, P., Castrén, K., Launonen, V., Soini, Y., Pääkkönen, K., Leisti, J., Vähäkangas, K., & Winqvist, R. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00258-1 · Cited by 28
Hao, Y., Montiel, R., Li, B., Huang, E., Zeng, L., & Huang, Y. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0907-y · Cited by 27
Balcı, A., Huusko, P., Pääkkönen, K., Launonen, V., Üner, A., Ekmekçi, A., & Winqvist, R. (1999) · European Journal of Cancer · doi:10.1016/s0959-8049(99)00014-3 · Cited by 27
The ‘other half’ of breast cancer: A review of male breast cancer
Ying, M., Agrawal, A., & Cheung, K. (2005) · The Journal of Men s Health and Gender · doi:10.1016/j.jmhg.2005.10.012 · Cited by 26
Loss of heterozygosity on the X chromosome in human breast cancer
Loupart, M., Adams, S., Armour, J. A. L., Walker, R. A., Brammar, W. J., & Varley, J. M. (1995) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870130402 · Cited by 25
Androgen Pathway Dysregulation in BRCA1-Mutated Breast Tumors
Berns, E. M. J. J., Dirkzwager-Kiel, M. M., Kuenen‐Boumeester, V., Timmermans, M. A. M., Verhoog, L. C., van den Ouweland, A. M. W., Meijers-Heijboer, H. E. J., Klijn, J. G. M., & van der Kwast, T. (2003) · Breast Cancer Research and Treatment · doi:10.1023/a:1023347409599 · Cited by 25
Radford, D., & Zehnbauer, B. (1996) · Surgical Clinics of North America · doi:10.1016/s0039-6109(05)70434-5 · Cited by 16
The biology of male breast cancer
Fentiman, I. S. (2018) · The Breast · doi:10.1016/j.breast.2018.01.001 · Cited by 24
Pharmacogenomics and Breast Cancer
Lymberis, S. C., Parhar, P. K., Katsoulakis, E., & Formenti, S. C. (2004) · Pharmacogenomics · doi:10.1517/phgs.5.1.31.25686 · Cited by 23
Bahuau, M., Laurendeau, I., Pelet, A., Assouline, B., LAMIREAU, T., TAINE, L., Bail, B. L., VERGNES, P., GALLET, S., Vidaud, M., et al. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.2.146 · Cited by 22
Plymate, S. R. (1994) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(18)30065-3 · Cited by 22
Androgen receptor and antiandrogen therapy in male breast cancer
Lauro, L. D., Barba, M., Pizzuti, L., Vici, P., Sergi, D., Benedetto, A. D., Mottolese, M., Speirs, V., Santini, D., Maria, R. D., et al. (2015) · Cancer Letters · doi:10.1016/j.canlet.2015.07.040 · Cited by 21
Kumar, A., Sharma, R., Faruq, M., Kumar, M., Sharma, S., Werner, R., Hiort, O., & Jain, V. (2021) · Sexual Development · doi:10.1159/000519047 · Cited by 20
Kumar, S., & Tyagi, R. K. (2012) · FEBS Journal · doi:10.1111/febs.12046 · Cited by 19
The role of androgen receptor gene mutations in male breast carcinoma
Hiort, O., Naber, S. P., Lehners, A., Muletta-Feurer, S., Sinnecker, G. H. G., Zollner, A. N., & Komminoth, P. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784104 · Cited by 20
Stewart, C. J. R., Baker, E., Beaton, C., Crook, M. L., Peverall, J., & Wallace, S. (2007) · Histopathology · doi:10.1111/j.1365-2559.2007.02927.x · Cited by 19
The management of familial breast cancer
Bennett, I., Gattas, M. R., & Teh, B. T. (2000) · The Breast · doi:10.1054/brst.2000.0208 · Cited by 19
Disorders of sex development: a genetic study of patients in a multidisciplinary clinic
Laino, L., Majore, S., Preziosi, N., Grammatico, B., Bernardo, C. D., Scommegna, S., Rapone, A. M., Marrocco, G., Bottillo, I., & Grammatico, P. (2014) · Endocrine Connections · doi:10.1530/ec-14-0085 · Cited by 19
Genetic Predisposition to Breast Cancer
Olsson, H. L., & Borg, Å. (1996) · Acta Oncologica · doi:10.3109/02841869609098472 · Cited by 19
Liu, Q., Yin, X., & Li, P. (2022) · Journal of Endocrinological Investigation · doi:10.1007/s40618-022-01894-4 · Cited by 18
Lobaccaro, J. A., Belon, C., Lumbroso, S., Olewniczack, G., Carré‐Pigeon, F., Job, J., Chaussain, J., Toublanc, J., & Sultan, C. (1994) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1994.tb03922.x · Cited by 18
Adeyinka, A., Mertens, F., Bondeson, L., Garne, J. P., Borg, Å., Baldetorp, B., & Pandis, N. (2000) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(99)00150-8 · Cited by 18
Winchester, D. J. (1996) · Seminars in Surgical Oncology · doi:10.1002/(sici)1098-2388(199609/10)12:5 · Cited by 18
Renal angiomyolipomata and learning difficulty in tuberous sclerosis complex
O'Callaghan, F. J., NOAKES, M., & OSBORNE, J. P. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.2.156 · Cited by 17
Yang, J., Zhao, S., Su, J., Liu, S., Wu, Z., Ma, W., Tang, M., Wu, J., Mao, E., Li, H., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1285508 · Cited by 15
Hereditary breast and ovarian cancer
Gronwald, J., Byrski, T., Huzarski, T., Oszurek, O., Janicka, A., Szymańska-Pasternak, J., Górski, B., Menkiszak, J., Rzepka-Górska, I., & Lubiński, J. (2008) · Hereditary Cancer in Clinical Practice · doi:10.1186/1897-4287-6-2-88 · Cited by 15
The Role of Androgens in Normal and Malignant Breast Tissue
Tiefenbacher, K., & Daxenbichler, G. (2008) · Breast Care · doi:10.1159/000158055 · Cited by 15
Santos, J. F. D. L., & Buchholz, T. A. (2000) · Current Treatment Options in Oncology · doi:10.1007/s11864-000-0033-x · Cited by 14
Shan, L., Yang, Q., Nakamura, M., Nakamura, Y., Mori, I., Sakurai, T., & Kakudo, K. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.3320 · Cited by 14
Teebi, A. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.2.145 · Cited by 14
Clinical geneticists' attitudes and practice towards testing for breast cancer susceptibility genes
Lucassen, A., & Houlston, R. S. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.2.157 · Cited by 13
Knoke, I., Jakubiczka, S., Ottersen, T., Göppinger, A., & Wieacker, P. F. (1997) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(96)00423-2 · Cited by 13
Androgen receptor and estrogen receptor variants in prostate and breast cancers
López, J. C. V., Lange, C. A., & Dehm, S. M. (2024) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2024.106522 · Cited by 13
Gynecomastia and Its Management In Boys With Partial Androgen Insensitivity Syndrome
Patjamontri, S., Lucas-Herald, A. K., Bryce, J., van den Akker, E. L. T., Cools, M., Globa, E., Guerra‐Júnior, G., Hiort, O., Hofman, P. L., Holterhus, P., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae562 · Cited by 12
Systematic identification of transcription factors associated with patient survival in cancers
Cheng, C., Li, L. M., Alves, P., & Gerstein, M. (2009) · BMC Genomics · doi:10.1186/1471-2164-10-225 · Cited by 12
Cheng, Y., Sun, Y., Ji, Y., Jiang, D., Teng, G., Zhou, X., Zhou, X., Li, G., & Xu, C. (2020) · Bioscience Reports · doi:10.1042/bsr20200616 · Cited by 12
Confirmation of a susceptibility locus on chromosome 13 in Australian breast cancer families
Grimmond, S. M., Palmer, J. M., Walters, M. K., Scott, C., Nancarrow, D. J., Teh, B. T., Elmes, C., Pyke, C., Khoo, S., Bennett, I., et al. (1996) · Human Genetics · doi:10.1007/s004390050164 · Cited by 12
Rajender, S., Francis, A., Singh, P., Krupakar, N., Surekha, D., Reddy, G., Rao, D. R., Rao, L., Ramachandra, S., Vishnupriya, S., et al. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-1263-7 · Cited by 11
Muñoz‐de‐Toro, M., & Luque, E. H. (1997) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/s0960-0760(96)00221-x · Cited by 11
Familial breast cancer and genes involved in breast carcinogenesis
Lindblom, A. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00665789 · Cited by 11
Syndromes associated with Homo sapiens Pol II regulatory genes
Bina, M., Demmon, S. L., & Parés-Matos, E. I. (2000) · Progress in nucleic acid research and molecular biology · doi:10.1016/s0079-6603(00)64005-9 · Cited by 10
HASTINGS, R. J., SVENNEVIK, E. C., SETTERFIELD, B., Wells, D., Delhanty, J. D. A., & MACKINNON, H. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.2.141 · Cited by 10
Mutations in the Androgen Receptor
Trapman, J., & Brinkmann, A. O. (1993) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1993.tb32273.x · Cited by 10
Prognostic Factors of Male Breast Cancer: Proteomic Approaches for Early Detection and Treatment
George, J., & Shukla, Y. (2008) · Journal of Proteomics & Bioinformatics · doi:10.4172/jpb.1000018 · Cited by 9
Plymate, S. R. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-388-0_3 · Cited by 8
Familial cancer syndromes and genetic counseling
Tomlinson, G. E. (1997) · Cancer treatment and research · doi:10.1007/978-1-4615-5767-8_3 · Cited by 8
Androgen receptor (CAG)n polymorphisms and breast cancer risk in a Han Chinese population
Dang, J., Peng, L., Zhong, H. J., & Huo, Z. (2015) · Genetics and Molecular Research · doi:10.4238/2015.august.28.10 · Cited by 7
Receptor Transduction Pathways Mediating Hormone Action
Kublaoui, B. M., & Levine, M. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-323-62520-3.00003-8 · Cited by 7
Wieacker, P. F., & Ledig, S. (2011) · Medizinische Genetik · doi:10.1007/s11825-011-0275-y · Cited by 7
Kasami, M., Yoshlda, M., Isogaki, J., Ogawa, H., Shinmura, K., Endo, Y., Kiyokawa, E., Naito, Y., Arai, T., Kimura, T., et al. (1997) · Pathology International · doi:10.1111/j.1440-1827.1997.tb03732.x · Cited by 7
BRCA/Fanconi anemia pathway genes in hereditary predisposition to breast cancer
Sólyom, S. (2011) · Cited by 7
Ha-ras rare alleles in breast cancer susceptibility
Conway, K., Edmiston, S. N., Fried, D. B., Hulka, B. S., Garrett, P. A., & Liu, E. T. (1995) · Breast Cancer Research and Treatment · doi:10.1007/bf00694750 · Cited by 7
Genetic Factors: Hereditary Cancer Predisposition Syndromes
Offit, K., Thom, P., & Bernstein, D. B. (2008) · Elsevier eBooks · doi:10.1016/b978-0-443-06694-8.50015-4 · Cited by 7
No evidence for imprinting in distal 18q
Maiwald, R., OVERHAUSER, J., & Laccone, F. A. (2000) · Journal of Medical Genetics · doi:10.1136/jmg.37.2.152 · Cited by 6
Novel BRCA2 mutation in a Polish family with hamartoma and two male breast cancers
Kwiatkowska, E. P., Brozek, I., Iżycka‐Świeszewska, E., Limon, J., & Mackiewicz, A. (2002) · Journal of Medical Genetics · doi:10.1136/jmg.39.7.e35 · Cited by 6
The Genetics of Testicular Germ Cell Tumours
Rapley, E. A., Crockford, G. P., Easton, D. F., Stratton, M. R., & Bishop, D. T. (2002) · Springer eBooks · doi:10.1007/978-1-4471-3281-3_1 · Cited by 6
5α-reductase inhibitors/finasteride
Stoner, E. (1996) · The Prostate · doi:10.1002/(sici)1097-0045(1996)6+ · Cited by 26
Willis, S., & Griffin, P. R. (2011) · Nuclear Receptor Signaling · doi:10.1621/nrs.09001 · Cited by 5
Receptor transduction pathways mediating hormone action
Kublaoui, B. M., & Levine, M. A. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00012-3 · Cited by 5
Molecular genetics of familial breast-ovarian cancer.
van Rensburg, E. J., & Ponder, B. A. J. (1995) · Journal of Clinical Pathology · doi:10.1136/jcp.48.9.789 · Cited by 5
Schrader, K. A., Sharaf, R., Alanee, S. R., & Offit, K. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-2865-7.00012-6 · Cited by 5
Disorders of Androgen Target Organs
Wieacker, P. F., Behre, H. M., & Nieschlag, E. (2010) · Springer eBooks · doi:10.1007/978-3-540-78355-8_17 · Cited by 5
The breast-ovarian cancer syndrome and BRCA1
Ford, D., & Easton, D. F. (1996) · Springer eBooks · doi:10.1007/978-1-4899-4501-3_15 · Cited by 5
Alterations and polymorphisms of the estrogen receptor gene in breast cancer
Iwase, H., & Kobayashi, S. (1997) · Breast Cancer · doi:10.1007/bf02967058 · Cited by 5
Breast Tumor Cytogenetic Markers
Slovak, M. L. (1997) · Humana Press eBooks · doi:10.1007/978-1-4612-3952-9_6 · Cited by 4
Mammakarzinom bei männlichen Patienten
Schwarz, L. E., & Schlag, P. M. (2002) · Der Onkologe · doi:10.1007/s761-002-8191-7 · Cited by 4
Clinical aspect of male breast cancer: a burgeoning and unaddressed issue
Ray, S. K., & Mukherjee, S. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10558-4 · Cited by 5
Hill, S. M., Klotz, D. M., & Cohn, C. S. (1996) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4266-6_7 · Cited by 3
Hereditary Breast-Ovarian Cancer
Philip, T. O. (2004) · Cited by 3
Teixeira, M. R., Pandis, N., & Heim, S. (2010) · doi:10.1002/9781118010136.ch15 · Cited by 3
Molecular Genetics of Androgen Insensitivity Syndromes in Humans
Pinsky, L., Trifiro, M. A., Beitel, L. K., & Kaufman, M. (1994) · Elsevier eBooks · doi:10.1016/b978-0-12-728960-1.50019-7 · Cited by 3
Commentary How many more breast cancer predisposition genes are there
Easton, D. F. (1999) · Cited by 3
Jenster, G. W., Trapman, J., & Brinkmann, A. O. (2001) · Elsevier eBooks · doi:10.1016/b978-012146160-7/50005-6 · Cited by 3
Teixeira, M. R., Pandis, N., & Heim, S. (2015) · doi:10.1002/9781118795569.ch16 · Cited by 3
Risk Assessment and Presymptomatic Molecular Diagnosis in Hereditary Breast Cancer
Merajver, S. D., & Petty, E. M. (1996) · Clinics in Laboratory Medicine · doi:10.1016/s0272-2712(18)30292-0 · Cited by 3
The Difference Between Male and Female Breast Cancer
Selleck, M., & Tiersten, A. (2004) · Principles of Gender-Specific Medicine · doi:10.1016/b978-012440905-7/50329-7 · Cited by 2
Receptor Transduction of Hormone Action
Rice, A. M., & Rivkees, S. A. (2008) · Elsevier eBooks · doi:10.1016/b978-141604090-3.50007-7 · Cited by 2
Schofield, A. C., Muir, E., Silva, D. D. C., Gregory, H., & Haites, N. E. (1996) · The Breast · doi:10.1016/s0960-9776(96)90059-4 · Cited by 2
Commentary on “Prevalence of BRCA1 and BRCA2 Mutations in Male Breast Cancer Patients in Canada”
Chappuis, P. O., & Foulkes, W. D. (2000) · Clinical Breast Cancer · doi:10.1016/s1526-8209(11)70099-4 · Cited by 2
Mechanismen der Entstehung genetisch bedingter Krebsformen
Scherneck, S., & Kölble, K. (1998) · Springer eBooks · doi:10.1007/978-3-642-80362-8_1 · Cited by 2
Alterations of Androgen Action Caused by Mutation of the Human Androgen Receptor
McPhaul, M. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-388-0_6 · Cited by 2
Genetic developments in breast cancer.
Favors, A. C. (1995) · PubMed · Cited by 2
Disorders of Androgen Target Organs
Meschede, D., Behre, H. M., & Nieschlag, E. (2001) · Springer eBooks · doi:10.1007/978-3-662-04491-9_11 · Cited by 2
Androgen Receptor in Transcriptional Regulation
Kallio, P. J., Ikonen, T., Moilanen, A., Poukka, H., Reinikainen, P., Palvimo, J. J., & Jänne, O. A. (1996) · Springer eBooks · doi:10.1007/978-3-662-03230-5_9 · Cited by 2
Genetics of Male Breast Cancer
Fentiman, I. S. (2025) · Springer eBooks · doi:10.1007/978-3-031-89929-4_3 · Cited by 1
Predisposing genes in hereditary breast and ovarian cancer
Huusko, P. (1999) · Cited by 1
DNA damage response genes and chromosome 11q21-q24 candidate tumor suppressor genes in breast cancer
Allinen, M. (2002) · Cited by 1
Androgens and the androgen receptor (AR)
Moore, N. L. T., Centenera, M. M., Butler, L. M., Hickey, T. E., & Tilley, W. D. (2013) · Cambridge University Press eBooks · doi:10.1017/cbo9781139046947.033 · Cited by 1
Fentiman, I. S. (2017) · Springer eBooks · doi:10.1007/978-3-319-04669-3_4 · Cited by 1
Metadata
- Authors
- Wooster, R., Mangion, J., Eeles, R., Smith, S., Dowsett, M., Averill, D., Barrett-Lee, P., Easton, D. F., Ponder, B. A. J., & Stratton, M. R.
- Affiliations
- Institute of Cancer Research (GB)
- University of Cambridge (GB)
- Royal Marsden NHS Foundation Trust (GB)
- ORCID
- Venue
- Nature Genetics
- Published
- 1992-10
- Volume
- 2
- Issue
- 2
- Pages
- 132-134
- ISSN
- 1061-4036 (ISSN-L)
- 1546-1718
- OpenAlex
- W2015688351
- Cited by
- 250
- References
- 26
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 2 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 1 · 2018: 2 · 2017: 2 · 2016: 3 · 2015: 7 · 2014: 5 · 2013: 4 · 2012: 2
- FWCI
- 22.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Genetics (publishedVersion)
- PubMed (publishedVersion)
- ORCA Online Research @Cardiff (Cardiff University) (submittedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Male Breast Health Studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Keywords
- androgen receptor, germline mutations, male breast cancer, androgen insensitivity syndrome, androgen resistance, X chromosome, DNA-binding domain, family history of breast cancer, steroid/thyroid hormone receptor superfamily, cancer susceptibility
- MeSH terms
- Aged, Base Sequence, Breast Neoplasms, DNA, DNA Mutational Analysis, Female, Germ Cells, Humans, Hypogonadism, Male, Middle Aged, Molecular Sequence Data, Pedigree, Receptors, Androgen, Syndrome, Point Mutation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review